Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk. Each month, I co-moderate a twitter discussion for those impacted by gynecologic ...

There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...

An analysis of over 1.2 million gynecologic cancer cases revealed a trend towards surgical de-escalation, with researchers observing a growing shift to minimally invasive techniques and sentinel lymph ...

The UAB Division of Gynecologic Oncology (GYN/ONC) serves as a major referral center for patients with gynecologic cancers in the state of Alabama, as well as the Southeast. We are a multidisciplinary ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), ...

Gynecologic oncology has shifted towards surgical de-escalation, emphasizing minimally invasive techniques and sentinel lymph node methods to reduce tissue injury while preserving oncologic outcomes.

In early 2018 the Gynecologic Oncology division partnered with UAB Care to take action against the opioid crisis. Dr. Michael Straughn, fellowship director for the division, approached the UAB Care ...

Symptoms of cervical, uterine, ovarian, and vaginal cancers can include abnormal vaginal bleeding or discharge; of ovarian cancer may include bloating, feeling full quickly, and abdominal or back pain ...

SERVICE FOR SOME CANCER PATIENTS WILL END AT MERCY ONE. IT WILL STOP OFFERING SURGERIES FOR CONDITIONS LIKE CANCER OF THE FEMALE REPRODUCTIVE SYSTEM. KCCI PEPPER PURPURA TELLS US WHAT’S NEXT. PEPPER.

Ready. Set. GO…. People are preparing to lace up their running shoes Saturday morning to support the work that’s being done at USA Health Mitchell Cancer Institute for gynecologic cancer research. The ...

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...